Ardent Health Partners ARDT Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount

Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount at other companies

Schneider NationalSNDR

$0-100%

PayPal Holdings, Inc.PYPL

$68M—

Schneider NationalSNDR

$0-100%

BKBK

$0—

Rockwell AutomationROK

$23M0.0%

BKBK

$394M+13.2%

Other financials

Income statement

See full

Revenue$1.6B+7.0%

Gross profit$1.6B+6.7%

Net income$39.9M-3.7%

EPS (diluted)$0.28-3.4%

Balance sheet

See full

Cash & equivalents$609.7M+23.2%

Total debt$1.2B+1.7%

Total equity$1.3B+13.8%

Total assets$5.3B+7.0%

Cash flow

See full

Operating cash flow-$60.2M-143%

CapEx$28.1M+22.6%

Free cash flow-$88.3M-85.2%

Valuation

See full

Market cap$1.35B-27.8%

Enterprise value$1.91B-24.3%

P/E10×+1.7×

P/S0.2×-0.1×

Profitability

See full

Gross margin97.5%-0.1pp

Net margin2.1%-1.6pp

FCF margin3.4%+1.4pp

Returns & leverage

See full

Return on equity10.7%-9.0pp

Debt / equity0.9×-0.1×

Current ratio2.1×0.0×

Where this comes from

Reported directly by Ardent Health Partners in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount.

The official record: Ardent Health Partners’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardent Health Partners's equity securities without readily determinable fair value, upward price adjustment, annual amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardent Health Partners's equity securities without readily determinable fair value, upward price adjustment, annual amount?: Ardent Health Partners (ARDT) reported equity securities without readily determinable fair value, upward price adjustment, annual amount of $10.9M in Q1 2026.